TradingMenu expanded
Forge Markets Browse Companies
DataMenu expanded
Forge Data IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Reports Private Market Data & Analytics Startup News
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Browse Companies
Data Menu expandedData
Forge Data
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Reports
Private Market Data & Analytics
Startup News
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Companies / Element Biosciences Stock

Element Biosciences Stock

elementbiosciences.comHealthcareFounded: 2017Funding to Date: $407.92MM

Element Biosciences developing disruptive DNA sequencing technology for research and diagnostic markets to empower customers with affordable high-quality data and an improved user experience.

Buy or sell Element Biosciences stockLearn more about Element Biosciences IPO
Register for Details

For more details on financing and valuation for Element Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Element Biosciences.

Register Today

Other companies like Element Biosciences in the Healthcare sector

Neuralink
Sector
Healthcare
Last Round Est. Valuation
$2.15B
Colossal Biosciences
Sector
Healthcare
 
 
Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.67B
Synchron
Sector
Healthcare
Last Round Est. Valuation
$400.53MM
Grail
Sector
Healthcare
Last Round Est. Valuation
$4.26B
OURA
Sector
Healthcare
 
 
Mammoth Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.08B
Cytonics
Sector
Healthcare
 
 
Precision Neuroscience
Sector
Healthcare
 
 

News

Genomeweb 03/14/2022
Element Biosciences Unveils New DNA Sequencing Instrument, Chemistry
The San Diego-based startup plans to address the US research market with its Aviti short-read sequencing platform and Avidity sequencing chemistry.
Genomeweb 02/22/2022
Element Biosciences Strikes Multiple Partnerships to Integrate Sequencer With Existing NGS Products
The collaborations will make the Aviti platform compatible with NGS products from Roche, Agilent Technologies, New England Biolabs, Qiagen, and Watchmaker Genomics.

Trending Companies

Frequently Asked Questions